ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

RANI Rani Therapeutics Holdings Inc

7.72
0.57 (7.97%)
07 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Rani Therapeutics Holdings Inc RANI 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.57 7.97% 7.72 09:00:00
개장가 저가 고가 종가 전일 종가
7.08 6.90 7.7199 7.56 7.15
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
07/05/202405:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/05/202405:05GLOBERani Therapeutics Reports First Quarter 2024 Financial..
07/05/202405:04EDGAR2Form 8-K - Current report
21/03/202405:05GLOBERani Therapeutics Reports Fourth Quarter and Full Year 2023..
16/03/202405:05GLOBERani Therapeutics to Report Fourth Quarter and Full Year..
05/02/202422:10EDGAR2Form 8-K - Current report
05/02/202422:00GLOBERani Therapeutics Announces Positive Topline Results from..
20/12/202306:06EDGAR2Form 8-K - Current report
20/12/202306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202322:05EDGAR2Form 8-K - Current report
14/12/202322:00GLOBERani Therapeutics Announces Preclinical Pharmacodynamic Data..
08/12/202307:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202306:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202306:10EDGAR2Form 8-K - Current report
09/11/202306:05GLOBERani Therapeutics Reports Third Quarter 2023 Financial..
02/11/202305:05GLOBERani Therapeutics Announces Strategic Program..
02/11/202305:04EDGAR2Form 8-K - Current report
25/10/202321:03EDGAR2Form 8-K - Current report
25/10/202321:00GLOBEThe RaniPill® Capsule, Rani Therapeutics’ Oral Delivery..
20/10/202305:05GLOBERani Therapeutics Announces Successful Oral Delivery of..
13/10/202305:05GLOBERani Therapeutics to Present Abstract on RT-102 at the 2023..
18/09/202321:00GLOBERani Therapeutics Initiates Phase 1 Study of RT-111..
08/09/202306:04EDGAR2Form 8-K - Current report
08/09/202305:05GLOBERani Therapeutics Announces Successful Drug Delivery of..
06/09/202321:00GLOBERani Therapeutics to Participate in September Investor..
12/08/202305:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/08/202305:05GLOBERani Therapeutics Reports Second Quarter 2023 Financial..
09/08/202305:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/08/202305:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/08/202305:05GLOBERani Therapeutics to Participate in August Investor..
21/06/202321:00GLOBERani Therapeutics’ Presentation On Oral Delivery of PTH for..
08/06/202321:00GLOBERani Therapeutics Announces Acceptance of Late-Breaking..
05/06/202321:00GLOBERani Therapeutics and Celltrion Expand Partnership to..
01/06/202321:00GLOBERani Therapeutics to Present at the Jefferies Healthcare..
31/05/202321:00GLOBERani Therapeutics Announces Acceptance of Three Abstracts..
24/05/202321:00GLOBERani Therapeutics Appoints Kate McKinley as Chief Business..
11/05/202305:05GLOBERani Therapeutics Reports First Quarter 2023 Financial..

최근 히스토리

Delayed Upgrade Clock